InvestorsHub Logo
Followers 21
Posts 2057
Boards Moderated 0
Alias Born 06/14/2007

Re: biotech_researcher post# 911

Wednesday, 03/04/2015 9:53:47 PM

Wednesday, March 04, 2015 9:53:47 PM

Post# of 2996
Something doesn't compute with Barclays $2.5b peak sales in that they also said the ex-US HCV sales (where ABBV has the better drug for gt1b) would be 70% of global revised up from their previous esimate of 45%.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News